CHEMICAL KINETICS AND STABILITY STUDIES OF AMLODIPINE BESYLATE
DOI:
https://doi.org/10.22270/ajprd.v6i2.364Keywords:
Amlodipine besylate, chemical kinetics, drug concentration, solubilityAbstract
The drug Amlodipine besylate was selected to study its chemical kinetics and degradation kinetics under variable conditions such as different temperatures, pH, light, buffers, solvent system and surfactants by applying the principles of chemical kinetics. The solubility of drug was checked in water and different solvents like Dimethyl formamide, methanol, ethanol, propylene glycol, PEG 400, PEG 600 and glycerol. The dug was found to be fully soluble in methanol, DMF, PEG 600, PEG 400, and Propylene glycol. The stock solution was then scanned between 200-400nm and the lmax was found to be 239 nm where the absorbance for 40 mg/ml was 1.1726 (Fig –1). The standard graph of the drug was plotted between concentration and absorbance whish gave a linear plot and the Lambert Beers law was obeyed in the concentration range of 0 to 30mg/ml.
Downloads
References
2. Guillory J. Keith and Rolland I. Poust, In; Gilbert S. Banker and Christopher T. Rhodes, Eds., Modern Pharmaceutics, 3rd Edn., rev. and expanded, Marcel Dekker Inc., New York, 1996;179-210.
3. E.H. Dearborn, In; J.J. Windheuser and W.L. Blockstein, Eds., University Extension, University of Wisconsin, Medison, WI, 1970; 29.
4. K. Nord., J. Karlsen, and H.H. Tonnesen, Int. J. Pharm., 1991; 11, 72.
5. P.J.G. Carnelissen, G.M.J. Beijersbergen Van Henegouwen, and K.W. Gerritsma, Int. J. Pharm., 1978;1, 173.
6. K.A. Neftel, M. Walti, Spengler, and A.L. De Weck, Lancet, 1982;1, 986.
7. Kenneth A. Connors, Gordon L. Amidon, Valentino J. Stella, Eds., In; Chemical Stability of Pharmaceuticals, 2nd Edn., A Wiley-Interscience Publication, New York, 1986;32-154.
8. Leon Lachman, Patrick Deluca, and Michael J. Akers, In; Leon Lachman, Herbert A. Lieberman, and Joseph L. Kanig, Eds., The Theory and Practice of Industrial Pharmacy, 3rd Edn., Varghese Publishing House, Bombay, 1987; 760-803.
9. Alfred Martin, James Swarbrick, Arthur Cammarata, Eds., In; Physical Pharmacy, 3rd Edn., Varghese Publishing House, Bombay, 1991; 350-397.
10. Federal Register, 36: 601, January 15, 1971.
11. Enever R.E., In; E.A. Rawlins, Eds., Bentley`s textbook of Pharmaceutics, 8th Edn., ELBS/Bailliere Tindall, East Sussex, 1984; 140-172.
12. Subrahmanyam C. V. S., Eds., In; Textbook of Physical Pharmaceutics, 1st Edn., Vallabh Prakashan, Delhi, 1998; 1-53.
13. “Martindale” The extra pharmacopoeia, 1999; 32nd Edn., 822-3.
14. Shefter Eli, Ho-Leung Fung, and Oliva Mok, J. Pharm. Sci., 1973; May, 62(5), 791-4.
15. Mathews A. Nunes and Einar Brochmanm-Hanssew, J. Pharm. Sci., 1974; 63(5), 716-20.
16. Beatrice M.G., Stanaszek W.F., Allen L.V., Stanton G.K., Cevington T.R., Am. J. Hosp. Pharm., 1975;32, 1133-7.
17. Genton D. and U.W. Kesselving, J. Pharm, Sci., 1977;66(5), 676-680.
18. Pikal M. J., A.L.Lukes and J.E.Lang, J. Pharm. Sci., 1977;66(9), 1312-1316.
19. Barbara Lenard Mc Niff, Edward F. McNiff and Ho-Hung Fung, Am. J. Hosp. Pharm. Sci., 1979; 36, 173-177.
20. Newten D.W., Fung E.Y., Williams D.A., Am. J. Hosp. Pharm., 1981;38, 1314-9.
21. Pawelczyk, Ewaryst, Knitter, Barbara, Majewski, Wiktor, Acta Pol Pharm., 1986;43(3). 142-9.
22. Jain N.K., Patel V.V., Taneja L.N., Pharmazie, 1988; 43(4), 254-5.
23. Wood M.J., Irwin W.J., Scott D.K., J. Clin. Pharm., Ther, 1990; 15, 291-300.
24. Sanyude, Locock, Robert A., Pagliaro and LouisA., J. Pharm. Sci., 1991;80(7), 674-6.
25. Xu K., Zhang H., Wee L., Lu Y., Sun K., and Yao Z., Zhongguo Zhong Yao Za Zhi, 1992;157-9, 191-2.
26. Chiba, Kaoru, Takahashi, Masanao, Byokin Yakugaku, 18(1), 43-51.
27. Yoshioka S., Aso Y., Izntsu K., and Kojuna S., Pharm. Res., 1994;11, 1721-5.
28. Blondino., Frank E, Byron., and Peter R., Respir. Drug Delivery V, Program Proc., (Int. Symp.), 1996, 5th, 125-131.
29. Thoma K., Kubler N., and Reimann E., Pharmazie, 1997;52, 362-73.
30. Shahrekh Z., Lee E., Olivero A.G., Matameros R.A., Robarge K.D., Lee A., Weise K.J., Blackum B.K., and Powell M.F., Pharm. Res., 1998;15, 434-41.
31. Nahata M.C., Marosco R.S., and Hipple T.F., J. Am.Pharm Assoc. (Warh), 39, 375-7.
32. Ekpe, Anthony, Jacobsen, and Thomas, Drug Der. Ind. Pharm., 1999;1057-1065.
33. El-Khawas, Manal, Boraie, and Nabila A, Acta Pharmaceutical (Zagreh), 2000;50(3), 219-228.
34. Pagocki, Dariusz, Schaneich, Christian, J. Pharm. Sci., 89(4), 443-6.
35. Kotchecvar A.T., Perry D.A., Ucken F.M., Drug Dev Ind Pharm., 2002;28(2), 143-9
Published
How to Cite
Issue
Section
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).